These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 19691683)

  • 1. Update on abuse-resistant and abuse-deterrent approaches to opioid formulations.
    Webster L
    Pain Med; 2009 Jul; 10 Suppl 2():S124-33. PubMed ID: 19691683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids.
    Woolf CJ; Hashmi M
    Curr Opin Investig Drugs; 2004 Jan; 5(1):61-6. PubMed ID: 14983975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained-release morphine sulfate with sequestered naltrexone for moderate to severe pain: a new opioid analgesic formulation and beyond.
    Ruan X
    Expert Opin Pharmacother; 2011 May; 12(7):999-1001. PubMed ID: 21470064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
    Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
    Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legal liability perspectives on abuse-deterrent opioids in the treatment of chronic pain.
    Brushwood DB; Rich BA; Coleman JJ; Bolen J; Wong W
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):333-48. PubMed ID: 21133741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of the nonmedical use of prescription opioid analgesics.
    Gilson AM; Kreis PG
    Pain Med; 2009 Jul; 10 Suppl 2():S89-100. PubMed ID: 19691688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous opioid treatment for chronic noncancer pain: a time for moderation in prescribing.
    Colameco S; Coren JS; Ciervo CA
    Postgrad Med; 2009 Jul; 121(4):61-6. PubMed ID: 19641271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for potential prescription opioid misuse in a michigan medicaid population.
    Braker LS; Reese AE; Card RO; Van Howe RS
    Fam Med; 2009; 41(10):729-34. PubMed ID: 19882397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?
    Edlund MJ; Sullivan M; Steffick D; Harris KM; Wells KB
    Pain Med; 2007; 8(8):647-56. PubMed ID: 18028043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abuse-deterrent formulations of prescription opioid analgesics in the management of chronic noncancer pain.
    Hale ME; Moe D; Bond M; Gasior M; Malamut R
    Pain Manag; 2016 Oct; 6(5):497-508. PubMed ID: 27050830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations.
    Gasior M; Bond M; Malamut R
    Postgrad Med; 2016 Jan; 128(1):85-96. PubMed ID: 26566680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foundations of opioid risk management.
    Katz NP; Adams EH; Benneyan JC; Birnbaum HG; Budman SH; Buzzeo RW; Carr DB; Cicero TJ; Gourlay D; Inciardi JA; Joranson DE; Kesslick J; Lande SD
    Clin J Pain; 2007 Feb; 23(2):103-18. PubMed ID: 17237659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Will abuse-deterrent formulations of opioid analgesics be successful in achieving their purpose?
    Bannwarth B
    Drugs; 2012 Sep; 72(13):1713-23. PubMed ID: 22931520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid analgesics for pain control: wisconsin physicians' knowledge, beliefs, attitudes, and prescribing practices.
    Wolfert MZ; Gilson AM; Dahl JL; Cleary JF
    Pain Med; 2010 Mar; 11(3):425-34. PubMed ID: 20002590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S1-65. PubMed ID: 22786448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamper-resistant opioid formulations in the treatment of acute pain.
    Passik SD
    Adv Ther; 2014 Mar; 31(3):264-75. PubMed ID: 24526323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches to improve pain relief while minimizing opioid abuse liability.
    Webster LR; Fine PG
    J Pain; 2010 Jul; 11(7):602-11. PubMed ID: 20444651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioids with abuse-deterrent properties: A regulatory and technological overview.
    Haddox JD
    J Opioid Manag; 2017; 13(6):397-413. PubMed ID: 29308587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002.
    Gilson AM; Ryan KM; Joranson DE; Dahl JL
    J Pain Symptom Manage; 2004 Aug; 28(2):176-88. PubMed ID: 15276196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.